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The secretedWnt signaling molecules are essential to the coordination
of cell-fate decisionmaking inmulticellular organisms. In adult animals,
the secreted Wnt proteins are critical for tissue regeneration and
frequently contribute to cancer. Small molecules that disable the Wnt
acyltransferase Porcupine (Porcn) are candidate anticancer agents in
clinical testing. Here we have systematically assessed the effects of the
Porcn inhibitor (WNT-974) on the regeneration of several tissue types
to identify potentially unwanted chemical effects that could limit the
therapeutic utility of such agents. An unanticipated observation from
these studies is proregenerative responses in heart muscle induced by
systemic chemical suppression of Wnt signaling. Using in vitro cultures
of several cell types found in the heart, we delineate theWnt signaling
apparatus supporting an antiregenerative transcriptional program that
includes a subunit of the nonfibrillar collagen VI. Similar to observa-
tions seen in animals exposed to WNT-974, deletion of the collagen VI
subunit, COL6A1, has been shown to decrease aberrant remodeling
and fibrosis in infarcted heart tissue. We demonstrate that WNT-974
can improve the recovery of heart function after left anterior descend-
ing coronary artery ligation by mitigating adverse remodeling of in-
farcted tissue. Injured heart tissue exposed to WNT-974 exhibits
decreased scarring and reduced Col6 production. Our findings support
the development of Porcn inhibitors as antifibrotic agents that could
be exploited to promote heart repair following injury.
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The replacement of normal tissue with collagen-laden scars isa major impediment to wound recovery following injury. In
heart tissue, a number of diverse disorders, including hypertro-
phic cardiomyopathy and heart failure, are associated with ex-
cessive deposition of fibrotic tissue (1). Whereas Wnt-mediated
signaling is well established as a participant in maladaptive fi-
brotic responses in most tissues, including the heart (2), selective
Wnt-signaling–targeted agents have been elusive, thus hamper-
ing efforts to pharmacologically exploit this understanding for
intervention in heart disease.
Despite the multitude of cellular responses that they elicit, all
19 secreted Wnt family members are dependent upon the same
biosynthetic enzymes, including Porcupine (Porcn), a multipass
acyltransferase localized to the endoplasmic reticulum (ER) that
supplies a single fatty acid adduct necessary for Wnt protein exit
from the secretory pathway (3–6). Transport of Wnt protein to
the cell surface from the ER requires interaction of the putative
lipoprotein receptor Wntless, a seven-transmembrane protein
that facilitates acylated Wnt protein secretion (7). Thus, Wnt
proteins that fail to be acylated are unable to exit the ER and are
unable to reach various Wnt receptors found on the cell surface.
From a small-molecule screen for Wnt pathway inhibitors, Porcn
emerged as a highly druggable target (8). Despite the intense in-
terest in Porcn inhibitors as anticancer agents, the importance of
Wnt signaling in diverse cell types—including fibroblasts, which
produce connective tissue—suggests that such agents could be
useful in regenerative medicine (9). Here we have applied the
clinical candidate Porcn inhibitor (WNT-974) to characterize the
response of diverse tissues to transient chemical suppression ofWnt
signaling. Although some tissues were predictably compromised by
loss of Porcn activity, heart muscle tissue saw increases in the mi-
totic activity of cells responsible for regeneration. We delineate,
using in vivo and in vitro approaches, the autonomous and noncell-
autonomous Wnt signals that support an antiregenerative state in
adult heart tissue. Using WNT-974, we demonstrate that infarcted
heart tissue with suppressed Wnt signaling shows decreased scar-
ring and improved heart function. We focus here on the profibrotic
molecule collagen VI as an effector protein complex of pro-
regenerative activities induced by Porcn inhibitors in heart cells.
Results
An in Vivo Screen to Identify Tissues Sensitive to Porcn Inhibitors. In
an effort to anticipate dose-limiting toxicities associated with the
use of Porcn inhibitors in clinical settings, we evaluated the
sensitivity of various murine adult tissues to WNT-974 exposure
at a dosage that previously has been associated with anticancer
activity but little toxicity (10, 11) (Fig. 1A). Given the central role
of Wnt signaling in gut epithelium renewal (12), we first confirmed
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the absence of weight change in animals treated using this drug-
delivery protocol (Fig. 1B). However, consistent with the impor-
tance of Wnt signaling in the gut epithelium, we noted a loss in the
number of proliferating cell nuclear antigen-positive (PCNA+) cells
in the jejunum crypt cells, which is indicative of decreased mitotic
activity (Fig. 1C and Fig. S1). These results suggest that in the
presence of cyclic exposure to Porcn inhibitors, gut epithelial stem
and progenitor cells are nevertheless able to sustain tissue renewal.
We examined the effects of systemic WNT-974 exposure on two
other tissues that are reliant upon Wnt signaling for regeneration:
hair follicles and cartilage (13, 14). In both tissue types, suppression
of Wnt signaling, following either depilation or the introduction of
puncture wounds in the ear, resulted in delayed hair and cartilage
regrowth (Fig. 1 D and E). Given the well-established role of Wnt/
β-catenin signaling in promoting bone formation (15), we then
determined the effects of Porcn inhibition on bone density as
measured in the tibia midshaft (Fig. 1F and Fig. S2) and meta-
phasis (Fig. S3). A notable loss of bone mass was observed, sug-
gesting bone health should be monitored in cases where Porcn
inhibitors may be used long-term. Thus, a chemical agent targeting
Porcn exhibits anticipated on-target effects in several tissues that
likely stem from loss of Wnt signaling.
Unexpectedly, heart tissue exposed to WNT-974 displayed an
increase in the mitotic activity of cardiomyocytes (CMs), sug-
gesting that health of the myocardium may be improved from
suppression of Wnt ligand expression (Fig. 1G). Taken together
with conclusions drawn from other in vivo studies using Porcn
inhibitors (11, 16, 17), our observations reveal potential dose-
limiting on-target activities of Porcn inhibitors in adult mam-
mals, but also reveal possible proregenerative cellular activity in
heart tissue with decreased Wnt protein production (Fig. 1H).
WNT-974 Alters the Expression of Profibrotic Genes in the Heart. The
recalcitrance of adult CMs to reentering the cell cycle poses a
significant challenge to the development of agents that directly
promote wound healing in heart tissue (18). We exploited the
responsiveness of homeostatic heart tissue to WNT-974 exposure
to identify Wnt-regulated cellular processes that may suppress
CM cell cycle reentry. Tissues exposed to WNT-974 exhibit a
significant change in expression of genes that contribute to
remodeling of the extracellular matrix (ECM), including several
that are associated with Wnt/β-catenin signaling (14, 19–21) (Fig.
2A and Dataset S1). For example, the secreted Wnt/β-catenin
signaling antagonist Dkk3 suppresses maladaptive remodeling of
infarcted tissue in mice and protects against cardiac dysfunction
after injury (22). The decreased expression of the Col6 subunit
(Col6a3) is also notable, given that Col6 has been shown to
suppress heart regeneration in injured murine heart tissue (23).
Animals null for COL6A1 show a marked improvement in heart
function and decreased scarring following left anterior descending
Fig. 1. Systematic identification of Porcn inhibition sensitivity in tissue regeneration. (A) The phase II clinical candidate WNT-974 inhibits both β-catenin–
dependent and –independent cellular responses. The TCF/LEF family of transcriptional regulators is directly activated by β-catenin. (B) WNT-974 dosed at 5 mg/kg
has little/no effect on animal weight compared with vehicle-treated animals. (C) PCNA staining of jejunum tissue derived from WNT-974 and vehicle-treated
animals. (Scale bar, 200 μm.) (D) Animals treated with WNT-974 (10 wk) fail to regrow hair after waxing compared with vehicle-treated animals. (E) Animals
treated with WNT-974 have delayed wound closure in the ear. Two-square millimeter ear hole punches were generated in vehicle and WNT-974–treated
animals and the area of unrecovered tissue measured 20 d later. (Scale bar, 1 mm.) (F) Representative 3D images of tibia midshaft cortical bone generated
using microcomputed tomography (μCT) in vehicle- or WNT-974–treated animals (10 wk). Bone volume fraction determination in the tibia midshaft using μCT.
(G) Doubling CMs (cTnT+, cardiac-specific isoform of troponin T; PH3+, marker for mitosis) are increased in WNT-974–treated animals (3 wk). Twenty sections
per animal were quantified. (Scale bar, 20 μm.) (H) A summary of adult tissue sensitivities to WNT-974 (or precursor molecule) presented in this study and by
other research groups at a concentration of 3–5 mg/kg. All tissues were analyzed under homeostatic conditions, unless otherwise indicated.
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(LAD) ligation, as in the case of WNT-974–treated animals. Sim-
ilar to other collagen proteins, a Col6 monomer comprises three
subunits (Col6a1, -a2, -a3) that are assembled in stoichiometric
fashion in the secretory pathway (24). Recessive mutations asso-
ciated with Ullrich congenital muscular dystrophy found in a single
subunit of Col6 are sufficient to eliminate the production of Col6
microfibrils, thus revealing the importance of coordinated subunit
expression (24). Notably, among the collagen gene family members
including those abundantly expressed in heart tissue, such as Col1
and Col3, the expression of Col6a3 was the most impacted by the
presence of WNT-974 (Fig. 2B) (25).
Wnt Signaling in the Heart. CMs, cardiac fibroblasts (CFs), and
endothelial cells (ECs) constitute the three major resident cell
types found in the murine heart, with ECs and CFs comprising
∼80% of the non-CM resident cells (26). We characterized the
Wnt expression profile in these cells using either cultured pri-
mary ECs and CFs, or CMs generated from induced pluripotent
stem cells (27). CMs engineered using this protocol have been
shown to faithfully model drug responses in heart tissues, exhibit
electrophysiological characteristics of true CMs, and can be
stably engrafted in living heart tissue (28–31). The expression of
only three Wnt genes was detectable using a quantitative PCR
(qPCR) strategy in these cells: Wnt5a/b in CFs and CMs, and
Wnt3 in CFs (Fig. 2C). Western blot analysis of Wnt5a/b and
Wnt3 protein in the medium of cultured cells confirmed that
Wnt proteins were indeed produced and secreted in CFs and
CMs, suggesting they are lipidated and functional (Fig. 2D). The
levels of phosphorylated Dishevelled 2 (Dvl2) protein, an activity
reporter of the Frizzled family of Wnt receptors (32), mirror
those of the abundance of secreted Wnt protein produced by
each cell type (Fig. 2C). We note that WNT-974 decreased the
levels of Wnt protein in the culture medium without inducing an
accumulation of presumably unlipidated Wnt protein in the se-
cretory pathway. Along with an absence of enriched expression
changes in genes associated with unfolded protein response
(Table S1), we conclude that WNT-974 does not induce ER
stress. Taken together, our in vitro studies reveal cell-autono-
mous and potential noncell-autonomous signaling events that
would be disabled by WNT-974 exposure in intact heart tissue
(Fig. 2E). These observations also suggest that among the three
major resident cell types in the heart, CFs likely exhibit the most
pronounced response to Porcn inhibitors in vivo.
As in other tissue types, fibroblasts found in the heart dictate
the composition of the ECM (33). Given that CFs elaborate the
entire repertoire of Wnt molecules expressed among the three
major resident heart cell types (Fig. 2C), we determined if sup-
pression of Wnt production by treatment with WNT-974 is suf-
ficient to inhibit the expression of the Col6 subunits Col6a1 or
Col6a3 (Fig. 2F). Despite the use of an excessively high con-
centration of WNT-974, we observed loss in the expression of the
matricellular gene connective tissue growth factor (CTGF), a
Wnt/β-catenin target gene (34), and a subunit of collagen 1
(Col1), but little change in the expression of Col6a1/a3.
To identify the non-CF cell type that exhibits WNT-974–sen-
sitive Col6 expression, we first determined if suppression of cell-
autonomous Wnt5a/b signaling in CMs using WNT-974 affected
Col6 expression (Fig. 2G). Although we saw no change in Col6
expression when WNT-974 was added alone, introduction of
Wnt3 expressing DNA into CMs induced Col6 in a WNT-974–
dependent manner. Our detection of changes in Col6a1 and
Col6a3 transcript abundance in CMs treated with recombinant
Wnt3a reveals a transcriptional activation-dependent mechanism
of Col6 expression controlled by Wnt signaling (Fig. 2H). On the
Fig. 2. WNT-974 induces changes in ECM regulatory gene expression in
normal heart tissue. (A) ECM composition in heart tissue is likely altered in
the presence of WNT-974. cDNA derived from 3× animals treated with ve-
hicle or WNT-974 was subjected to microarray analysis. DAVID software (48)
was used to identify cellular processes that were altered by exposure to
WNT-974 (with genes ≥1.5 fold-change). Asterisks (*) denote known targets
of Wnt/β-catenin signaling or signaling regulators. (B) Expression changes in
collagen family members introduced by WNT-974 exposure in heart tissue.
(C) qPCR profiling of Wnt molecules expressed in three major heart resident
cell types cultured in vitro. CMs were generated from induced pluripotent
stem cells; ECs and CFs are primary cells from human heart tissue. (D) CFs
exhibit the most robust cell-autonomous Wnt signaling as measured using
phosphorylation of the Dvl2 signaling molecule, a general marker of Frizzled
receptor activation by Wnt proteins. WNT-974 decreased the abundance of
secreted Wnt proteins in the culture medium and turnover of presumably
unlipidated Wnt protein in the secretory pathway. (E) A map of potential
Wnt-mediated cell-to-cell signaling interactions among the three most
abundant heart cell types. (F) Inhibition of cell-autonomous Wnt signaling in
CFs using a high concentration of WNT-974 does not alter Col6 expression as
measured by Col6a1 and Col6a3 mRNA abundance. CTGF is a target gene of
Wnt/β-catenin signaling. CFs are known to express Col1, an abundant ECM
protein found in heart tissue (25). (G) Col6 expression in CMs as determined
using Western blot analysis is controlled by lentivirus-mediated introduction
of Wnt3 DNA. Loss of cell autonomous Wnt5a/b signaling induced by WNT-
974 exposure does not impact Col6 expression (see E). Dvl2 phosphorylation
serves as a marker of cell-autonomous Wnt signaling status. (H) Purified
Wnt3a protein induces transcriptional activation of Col6 gene expression in
CMs but not ECs. # denotes undetectable. (I) A model of antiregenerative
Wnt signaling in heart tissue that is disabled by Porcn antagonists. Wntless
(Wls) is a chaperone protein that facilitates the exiting of acylated Wnt
proteins.
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other hand, ECs failed to respond to Wnt3a protein, suggesting
that CMs are the primary effector cells of WNT-974 action at
least with respect to Col6 expression. When taken together, our
observations suggest that Porcn inhibitors inhibit Wnt3 protein
production from CFs, thus reducing the production of Col6 ex-
pression in CMs (Fig. 2I).
Chemical Inhibition of Porcn Improves Heart Function Recovery
Following Myocardial Infarction. The effects of WNT-974 in de-
creasing the expression of profibrotic genes, such as Col6, sug-
gests that targeting Porcn may be a useful approach for promoting
wound healing in infarcted heart tissue. We determined the effects
of WNT-974 on recovery in infarcted heart tissue provoked by
permanent ligation of the LAD coronary artery. In two blinded
studies, animals were equally segregated into cohorts for vehicle or
WNT-974 treatment based on echocardiography (Fig. S4) or MRI
(Fig. 3A, Fig. S5, and Table S2) following LAD ligation. Although
area at risk was not measured, the extent of left ventricular dys-
function as measured by ejection fraction was similar in both groups
before treatment, consistent with equivalent injury (Fig. 3B). Dosing
of animals was initiated 1 wk following LAD occlusion, then con-
tinued for 10 wk. Animals treated with WNT-974 for 10 wk
exhibited improved heart function compared with those treated
with vehicle alone, as measured by ejection fraction (Fig. 3B). No
change was observed in the heart rate of mice treated with WNT-
974 compared with vehicle (Fig. 3C). We also noted that WNT-974
reduced injury-induced heart weight gain (Fig. 3D) and ventricular
dilation (Fig. 3 E and F), which is consistent with improvements in
heart function observed in the WNT-974–treated animals.
Porcn Inhibition Reduces Scarring in Heart Tissue. Histological ex-
amination of heart tissue revealed reduced scarring in animals
with Wnt suppression (Fig. 4). We also observed a reduced
number of CMs expressing Col6 in the infarcted area of mice
treated with WNT-974 (Fig. S6). Notably, Col6 is not readily
detected in uninjured heart tissue confirming that Col6 is in-
duced following injury, as previously described (23). Taken to-
gether, these observations suggest Porcn inhibitors promote
functional recovery of heart tissue primarily by mitigating scar-
ring that may in part be attributable to loss in expression of the
anti-regenerative molecule Col6.
Discussion
Wound repair in heart tissue is often described as a three-phase
process composed of periods of inflammation, proliferation, and
healing (35). The contribution of Wnt signaling in each of
these phases is the subject of ongoing studies (36) and an un-
derstanding of these relationships has direct bearing on the op-
timal recovery response that can be ultimately achieved with
Porcn inhibitors. Excessive deposition of collagen proteins in
particular is problematic, given their slow turnover rate, which
limits efforts to remove scar tissue once it is established (37). We
show that the Porcn inhibitor WNT-974 prevents collagen pro-
duction in CMs by blocking secretion of Wnt3, a profibrotic
agonist, from CFs and its signaling to CMs.
Another study using a precursor compound of WNT-974
(GNF-6231) given at a comparable drug concentration recently
reported similar proregenerative effects in heart tissue, including
improvements in heart function following Porcn inhibition and
reduced scarring (38). The immediate delivery of a Porcn in-
hibitor following LAD ligation in that study suggests that sup-
pression of Wnt responses during the inflammatory phase does
not contribute to the improvements in heart recovery seen in
WNT-974–treated animals. At the same time, the success of our
approach (a 1-wk delay in drug delivery following injury) reveals
at a minimum a 1-wk window in which initiation of Porcn in-
hibitor delivery following myocardial infarction (MI) might be
beneficial. Finally, we acknowledge that changes in the expres-
sion of Col6 may be only one proregenerative consequence of
Porcn inhibition and that other molecular changes (38, 39) may
also be factors that influence heart function outcome.
Porcn inhibitors are likely to also target tissue-specific mech-
anisms supporting fibrosis or that suppress the activity of resident
stem/progenitor cells. For example, epicardial cells responding to
Wnt signals after injury have been shown to undergo epithelial-
to-mesenchymal transition and adopt fibroblastic features in
the subepicardium of injured neonatal heart tissue (40). Sup-
pression of Porcn activity may blunt this phenomenon, in ad-
dition to influencing the activity of resident fibroblasts in the
heart. A recent study using GNF-6231 also revealed potential
increased doubling in the cardiac progenitor population fol-
lowing injury (38). Thus, activation of stem/progenitor cells by
direct/indirect action of Porcn inhibitors may also contribute to
improvements in regeneration in some tissues. Finally, although not
addressed in this study, changes in the ECM composition because of
Porcn inhibition may influence other heart repair processes, such as
angiogenesis and inflammation (41).
Despite the importance ofWnt signaling in cancer and the intense
interest in Porcn inhibitors as anticancer agents, the contribution of
Wnt proteins in cell-fate decision making and in transcriptional
regulation in fibroblasts suggests that such agents could be useful
in other therapeutic arenas, including regenerative medicine (9).
Our in vivo chemical screen using WNT-974 has identified a
tissue that is not detrimentally affected by suppression of Wnt
signaling and that may benefit from diminished fibrotic responses
induced by Porcn inhibition. Indeed, other classes of small molecules
with inhibitory activity for Wnt signaling have similarly shown
Fig. 3. Inhibition of Porcn improves heart function after LAD ligation.
(A) Diagram showing strategy of procedure. One week following LAD ligation
(MI), mice were subjected to MRI to determine pretreatment heart function.
Mice were dosed with either WNT-974 (5 mg/kg; 1× by mouth each day) or
vehicle for 10 wk. Heart function was then determined using MRI (post-
treatment MRI). (B) Ejection fraction of pre- and posttreated mice. (C) Heart
rate of vehicle or WNT-974–treated animals. (D) Heart weight of vehicle or
WNT-974–treated animals. Normal heart weight for a 6-mo-old male C57BL/6
mouse is ∼200 mg (49). (E) Left ventricular end-diastolic volume (LVEDV) of
vehicle or WNT-974–treated animals. (F) Left ventricular end- systolic volume
(LVESV) of vehicle or WNT-974–treated animals.
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beneficial responses in heart tissue; albeit, these molecules have
not progressed further in clinical development for managing
heart disease (42, 43). We also reason that other tissues, like
the heart (Fig. 5), not yet fully investigated with Porcn inhibitors
may also see similar benefits upon inhibition of Wnt ligand
production. Indeed, these agents have been also shown to blunt
kidney fibrosis induced by a murine model of obstructive ne-
phropathy (44).
Age-dependent increases in circulating Wnt molecules promote
fibrotic responses at the cost of meaningful muscle restoration after
injury (45). Life expectancy following heart attacks drops pre-
cipitously with increasing age after the age of 60 (46). Thus, an
important next step is to demonstrate that proregenerative re-
sponses to Porcn inhibitors are preserved in aged animals. The use
of such agents for tissue repair after injury will likely require
transient chemical exposure, thus bypassing many of the on-target
effects that may complicate the long-term delivery of these mole-
cules in cancer management.
Materials and Methods
Wnt-974 Treatment. C57BL/6 mice [12-wk-old (LAD studies) or 3- to 12-mo-old
(other studies)]wereused.Wnt-974 (ActiveBiochem)wasprepared in0.5%(wt/vol)
methylcellulose (Sigma)/0.5% (vol/vol) Tween-80 (Sigma) and administered by oral
gavageat 5mg/kgpermouseonceperday for indicated timeperiods, as previously
described (47). All animal experiments were performed in accordance to regula-
tory standards as accepted by the Institutional Animal Care and Use Committee at
the University of Texas Southwestern Medical Center.
Microarray and qPCR. Methods for microarray and qPCR are described in SI
Materials and Methods.
Bone Density Analysis.Micro-CT35 imaging system (Scanco Medical) was used
to assess trabecular and cortical bone morphology. High-resolution scans
(3.5-μm slice increments) of the long bone with 200 slices selected for analyses
of the midshaft, and with 100 slices selected for analyses of the metaphysis
area, were taken. The data were analyzed by using Scanco Medical software.
Fig. 4. Porcn inhibition reduces scarring in infarcted heart tissue. (A) Location of sections at four different levels relative to the LAD ligation position used for
histological analysis of WNT-974– or vehicle-treated animals with LAD ligation. (B) Trichrome staining was used to visualize scar tissue in five different hearts
from each animal treatment group. (C) Quantification of results in B. (D) Staining of heart sections with picrosirius red reveals decreased collagen deposition
in WNT-974–treated animals. (E) Quantification of results in D.
Fig. 5. A model for chemically assisted adult heart repair using Porcn in-
hibitor. Disruption of Wnt production in fibroblast/myofibroblasts by Porcn
inhibitor reduces excess deposition of ECM proteins following heart injury,
thus promoting heart repair.
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MI and Drug Treatment. Methods for MI and drug treatment are described in
SI Materials and Methods.
Cardiac MRI. Methods for cardiac magnetic resonance imaging are described
in SI Materials and Methods.
Histology and Immunostaining. Methods for histology and immunostaining
are described in SI Materials and Methods.
Cell Culture, Recombinant Wnt Proteins, and Lentiviral Transduction. Methods
for cell culture, recombinant Wnt proteins, and lentiviral transduction are
described in SI Materials and Methods.
Western Blot Analysis. Methods for Western blot analysis are described in SI
Materials and Methods.
Statistical Analysis. Values are displayed as mean ± SEM. Student’s t test was
performed for unpaired analysis. P < 0.05 was considered statistically significant.
Availability of Data and Materials. Our data and materials may be made
available upon request to the corresponding author.
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